loop diuretics + thiazide diuretics

A combination of loop diuretics and thiazide diuretics is used primarily in the management of fluid overload, especially in patients with heart failure who are resistant to either drug alone. Loop diuretics (such as furosemide, bumetanide, torasemide) act by inhibiting the sodium-potassium-chloride co-transporter in the thick ascending limb of the loop of Henle, leading to significant natriuresis and water loss. Thiazide or thiazide-like diuretics (such as hydrochlorothiazide, metolazone) inhibit sodium-chloride reabsorption in the distal convoluted tubule. The rationale for combining these two classes is "sequential nephron blockade," which targets different sites along the nephron to overcome compensatory mechanisms that limit single-agent efficacy and can produce a synergistic effect on sodium excretion[2][5][6]. This combination is particularly useful for patients with acute decompensated heart failure who develop resistance to high-dose loop diuretic therapy[1][3]. However, this regimen increases risks such as hypokalemia, hyponatremia, hypotension, and worsening renal function; therefore close monitoring is required[2][4].